COVID case study
Applications closed 7 September 2020
I am offering a number of case study places to people who are recovering from COVID-19. The purpose of this case study programme is to assess the effectiveness of microbiome treatment in the lasting symptoms of Long Covid and Covid recovery. This will test my own hypotheses, drawn from the latest medical research, about the role of the microbiome in longterm COVID symptoms. There is good evidence for the role of the microbiome in reducing inflammatory symptoms, however this case study programme does not guarantee any outcome.
I aim to use the findings of the study to inform my private Microbiome Analysis practice so I can support people in their recovery from COVID more effectively. I intend to publish the findings, share details with other microbiome practitioners and potentially use the results to call for more research and microbiome support for people recovering from COVID. Applications have now closed. To hear about the progress and results of this study, please add your email address here.
I am delighted that the testing company I use for stool testing, Biomesight, will be sponsoring the first phase by providing testing kits. While I will be donating my time and consultation fees, there may be some costs incurred: to pay for any prebiotics or probiotics I prescribe. This is likely to be less than a total of £180, spread over 3 months, and I am also looking for funding to make this more accessible. If you are interested in sponsoring a participant, please get in contact.
To participate, you will need to be able to commit to 3–6 online consultations as well as reasonable dietary changes for a period of around 3 months between September and December 2020.
My background includes an early career as a published biomedical research scientist, as well as 15 years in natural healthcare practice, specialising in digestive health, trauma recovery and chronic fatigue conditions. I also have personal experience of 15 years of ME/CFS and recovery, so you can expect an understanding approach to your ongoing COVID symptoms. To learn more about the process and my approach, please read about Microbiome Analysis and about me. You can also read about the proposed role of the microbiome in the more severe symptoms of COVID here.
Applications closed on 7 September 2020. There are limited places and I am selecting case study participants that represent a range of symptoms and experiences. I will let you know – either way – whether your application is selected, but if I receive many applications, I may not be able to enter into a conversation about your application if it's not selected. I will retain the details you give me in your application securely, according to EU GDPR data protection legislation, for as long as is needed for the purposes of this case study programme, or until you request I securely destroy the information you give me.
Many thanks to those who have submitted an application. If I haven't yet been in touch, I will be very soon.
Gu et al (June 2020) Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza, Clinical Infectious Diseases
He et al (June 2020) Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection, Frontiers in Microbiology
Trottein & Sokol (July 2020) Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection, Cell Reports 32(3)
Please note: the test results and the Microbiome Analysis consultations do not include or substitute medical advice, nor do they provide a diagnosis of any condition. I do not advise on medication and any changes in medication should always be made in consultation with your prescriber. Some dietary or lifestyle recommendations may require consultation with your GP or other health practitioner. I do not accept commission or affiliate fees for any of the probiotic or prebiotic supplements I may recommend